SCHEMBL2298027

SCHEMBL2298027

C=Cc1ccc(-c2nnc(N(CCCC)C(=O)c3ccccc3OC)s2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 15/20 0.70
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 1/20 0.54
HPGD P15428 1/20 0.54
UBE2N P61088 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CPB1 P15086 1/20 0.53
S1PR3 Q99500 6/20 0.53
S1PR4 O95977 1/20 0.50
S1PR5 Q9H228 1/20 0.50
MEN1 O00255 1/20 0.48
CYP1A2 P05177 1/20 0.48
GAA P10253 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2299749 0.92 S1PR1 (0.71) S1PR1NPC1RAB9AL3MBTL1KDM4E
SCHEMBL12779863 0.87 S1PR1 (0.69) S1PR1S1PR3S1PR4S1PR5
SCHEMBL2297863 0.82 RAB9A (0.63) S1PR1NPC1RAB9AL3MBTL1KDM4E
SCHEMBL1971713 0.82 S1PR1 (0.71) S1PR1NPC1RAB9AL3MBTL1KDM4E
SCHEMBL2300314 0.81 S1PR1 (0.64) S1PR1ALDH1A1SMN1; SMN2HSD17B10CPB1
SCHEMBL1966067 0.80 S1PR1 (1.00) S1PR1NPC1RAB9AL3MBTL1S1PR3
SCHEMBL1647950 0.79 CPB1 (0.72) S1PR1NPC1RAB9AL3MBTL1KDM4E
SCHEMBL2298171 0.79 S1PR1 (0.59) S1PR1NPC1RAB9AL3MBTL1KDM4E
SCHEMBL2300065 0.79 S1PR1 (0.69) S1PR1NPC1RAB9AKDM4EALDH1A1
SCHEMBL27838329 0.78 S1PR1 (0.85) S1PR1NPC1RAB9AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
WO-2010043377-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES S1PR2, S1PR3, S1PR1 S1PR1 3/4885NPC1 378/4885RAB9A 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.